These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

82 related items for PubMed ID: 8563010

  • 1. TUDCA and UDCA are incorporated into hepatocyte membranes: different sites, but similar effects.
    Leuschner U, Guldutuna S, Bhatti S, Elze A, Imhof M, You T, Zimmer G.
    Ital J Gastroenterol; 1995 Sep; 27(7):376-7. PubMed ID: 8563010
    [Abstract] [Full Text] [Related]

  • 2. Modulation of rat hepatocyte proliferation by bile salts: in vitro and in vivo studies.
    Barone M, Francavilla A, Polimeno L, Ierardi E, Romanelli D, Berloco P, Di Leo A, Panella C.
    Hepatology; 1996 May; 23(5):1159-66. PubMed ID: 8621149
    [Abstract] [Full Text] [Related]

  • 3. Effects of ursodeoxycholic acid and chenodeoxycholic acid on human hepatocytes in primary culture.
    Hillaire S, Ballet F, Franco D, Setchell KD, Poupon R.
    Hepatology; 1995 Jul; 22(1):82-7. PubMed ID: 7601437
    [Abstract] [Full Text] [Related]

  • 4. Differential regulation of cyclin D1 and cell death by bile acids in primary rat hepatocytes.
    Castro RE, Amaral JD, Solá S, Kren BT, Steer CJ, Rodrigues CM.
    Am J Physiol Gastrointest Liver Physiol; 2007 Jul; 293(1):G327-34. PubMed ID: 17431217
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [The influence of chenodeoxycholic acid and ursodeoxycholic acid on the hepatic structure of the rat (author's transl)].
    Leuschner U, Schneider M, Korte L.
    Z Gastroenterol; 1979 Apr; 17(4):244-55. PubMed ID: 433375
    [Abstract] [Full Text] [Related]

  • 7. Hydrophilic but not hydrophobic bile acids prevent gallbladder muscle dysfunction in acute cholecystitis.
    Xiao ZL, Biancani P, Carey MC, Behar J.
    Hepatology; 2003 Jun; 37(6):1442-50. PubMed ID: 12774024
    [Abstract] [Full Text] [Related]

  • 8. Further observations on the in vitro metabolism of chenodeoxycholic acid and ursodeoxycholic acid.
    Albini E, Marca G, Mellerio G.
    Arzneimittelforschung; 1982 Jun; 32(12):1554-7. PubMed ID: 6891595
    [Abstract] [Full Text] [Related]

  • 9. Cytotoxicity of bile salts against biliary epithelium: a study in isolated bile ductule fragments and isolated perfused rat liver.
    Benedetti A, Alvaro D, Bassotti C, Gigliozzi A, Ferretti G, La Rosa T, Di Sario A, Baiocchi L, Jezequel AM.
    Hepatology; 1997 Jul; 26(1):9-21. PubMed ID: 9214446
    [Abstract] [Full Text] [Related]

  • 10. Toxicity of ethanol and acetaldehyde in hepatocytes treated with ursodeoxycholic or tauroursodeoxycholic acid.
    Henzel K, Thorborg C, Hofmann M, Zimmer G, Leuschner U.
    Biochim Biophys Acta; 2004 Feb 02; 1644(1):37-45. PubMed ID: 14741743
    [Abstract] [Full Text] [Related]

  • 11. Effects of treatment with deoxycholic acid and chenodeoxycholic acid on the hepatic synthesis of cholesterol and bile acids in healthy subjects.
    Einarsson C, Hillebrant CG, Axelson M.
    Hepatology; 2001 May 02; 33(5):1189-93. PubMed ID: 11343248
    [Abstract] [Full Text] [Related]

  • 12. Binding studies of bile acids using the native fluorescence of the tryptophan residue Of Bax protein.
    Zhang W, Steer CJ, Douglas KT, Rodrigues CM.
    Biosci Rep; 2006 Jun 02; 26(3):245-50. PubMed ID: 16850250
    [Abstract] [Full Text] [Related]

  • 13. Ursodeoxycholate and tauroursodeoxycholate inhibit cholangiocyte growth and secretion of BDL rats through activation of PKC alpha.
    Alpini G, Baiocchi L, Glaser S, Ueno Y, Marzioni M, Francis H, Phinizy JL, Angelico M, Lesage G.
    Hepatology; 2002 May 02; 35(5):1041-52. PubMed ID: 11981754
    [Abstract] [Full Text] [Related]

  • 14. Chronic administration of ursodeoxycholic and tauroursodeoxycholic acid changes microsomal membrane lipid content and fatty acid compositions in rats.
    Bellentani S, Chao YC, Ferretti I, Panini R, Tiribelli C.
    Biochem Biophys Res Commun; 1996 Mar 27; 220(3):479-83. PubMed ID: 8607791
    [Abstract] [Full Text] [Related]

  • 15. Tauroursodeoxycholic acid protects rat hepatocytes from bile acid-induced apoptosis via activation of survival pathways.
    Schoemaker MH, Conde de la Rosa L, Buist-Homan M, Vrenken TE, Havinga R, Poelstra K, Haisma HJ, Jansen PL, Moshage H.
    Hepatology; 2004 Jun 27; 39(6):1563-73. PubMed ID: 15185297
    [Abstract] [Full Text] [Related]

  • 16. Tauroursodeoxycholic acid prevents Bax-induced membrane perturbation and cytochrome C release in isolated mitochondria.
    Rodrigues CM, Solá S, Sharpe JC, Moura JJ, Steer CJ.
    Biochemistry; 2003 Mar 18; 42(10):3070-80. PubMed ID: 12627974
    [Abstract] [Full Text] [Related]

  • 17. Bile acids and apoptosis modulation: an emerging role in experimental Alzheimer's disease.
    Ramalho RM, Viana RJ, Low WC, Steer CJ, Rodrigues CM.
    Trends Mol Med; 2008 Feb 18; 14(2):54-62. PubMed ID: 18218342
    [Abstract] [Full Text] [Related]

  • 18. Permeability of the rat biliary tree to ursodeoxycholic acid.
    Farges O, Corbic M, Dumont M, Maurice M, Erlinger S.
    Am J Physiol; 1989 Apr 18; 256(4 Pt 1):G653-60. PubMed ID: 2705526
    [Abstract] [Full Text] [Related]

  • 19. Relationship between structure and intestinal absorption of bile acids with a steroid or side-chain modification.
    Aldini R, Roda A, Montagnani M, Cerrè C, Pellicciari R, Roda E.
    Steroids; 1996 Oct 18; 61(10):590-7. PubMed ID: 8910972
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of the MAPK and PI3K pathways enhances UDCA-induced apoptosis in primary rodent hepatocytes.
    Qiao L, Yacoub A, Studer E, Gupta S, Pei XY, Grant S, Hylemon PB, Dent P.
    Hepatology; 2002 Apr 18; 35(4):779-89. PubMed ID: 11915023
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.